Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

DANIEL STEWART RESEARCH ARM CONTINUES TO EXCEL

3rd Jun 2009 07:00

RNS Number : 2283T
Daniel Stewart Securities PLC
03 June 2009
 



June 2009

DANIEL STEWART SECURITIES PLC

(AIM)

("Daniel Stewart"," the Group" or "the Company")

DANIEL STEWART RESEARCH ARM CONTINUES TO EXCEL

Pharmaceuticals analyst provides shot in the arm as stock picks rocket

The Board of Daniel Stewart Securities plc is pleased to announce that Vadim Alexandre, a member of staff of Daniel Stewart & Company plcthe Group's investment subsidiary which offers corporate advisory and institutional stockbroking services with a focus on small and mid-sized companieshas been named top Pharmaceuticals and Biotechnology analyst by Shares Magazine in its 2009 awards.

Vadim's winning pick was Asterand plcwhose share price has increased nearly 300% since it was first recommended in May of last year. Vadim's expert stock picking has helped to cement Daniel Stewart's reputation as a leading broker in the Healthcare sector. Recently published Hemscott data ranks Daniel Stewart third in the Healthcare arena by number of clients.

New Hires

As announced on June 2009 Christian Wiss joined Daniel Stewart as Head of Sales. Christian was previously with Neue Zurcher Bank where he was in Market Sales / Research specialising in Financials, Biotech and Pharma stocks. Prior to that, he worked in sales and research for Fox-Pitt and Dresdner Kleinwort Wasserstein.

Stephen Roberts, Head of Corporate Finance, commenced work at Daniel Stewart on 5 May 2009 and has extensive experience having previously held senior positions at Fairfax IS plc, Collins Stewart plc and Evolution Securities plc.

Daniel Stewart continues to focus on providing strong sector-based research expertise and has recently hired Oil &Gas analyst Leila Reddy who was previously at Libertas Capital and, prior to that, at Banard Jacobs Mellet Securities in Johannesburg

Peter Shea, Chief Executive of Daniel Stewart says:

"We are delighted that our research team continues to prove itself. We believe strongly in providing sectoral expertise and analysis and this strategy is really paying dividends. 

"Earlier this year we announced an agreement for the distribution of our research into the United States confirming the outstanding quality of our research product. I see plenty more opportunity to tap into the American market in the coming months.

Enquiries, please contact:

Daniel Stewart & Company plc

Peter Shea Tel: 020 7776 6550

Bishopsgate Communications Ltd.

Maxine Barnes/Nick Rome Tel: 020 7562 3350

Notes to Editors:

About Daniel Stewart

Daniel Stewart Securities is an AIM-listed company providing a range of investment banking services to Small Cap publicly traded and non-publicly traded companies. The Group has two subsidiaries, Daniel Stewart and Company, the Group's principal operating subsidiary, which is authorised and regulated by the Financial Services Authority and is a member of the London Stock Exchange, and Daniel Stewart Capital, the Group's leasing and debt financing division.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAELLFBKQBBBBB

Related Shares:

Daniel Stewart Securities Plc
FTSE 100 Latest
Value8,585.01
Change-17.91